Sandbox Reserved 1482: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
== History == | == History == | ||
'''1937''': first use of the factor VIII (known at this period as “Antihemophilic Globulin”) to cure the blood coagulation disorder of hemophilia patients thanks to the discovery of F.H.L Patek and A.J Taylor <ref>Patek AJ & Taylor FHL. Hemophilia. II. Some properties of a substance obtained from normal human plasma effective in accelerating the coagulation of hemophilic blood. The Journal of clinical investigation. 1937 Jan; 16(1): 113-124. PMID: 16694450 doi: 10.1172/JCI100829</ref>. | '''1937''': first use of the factor VIII (known at this period as “Antihemophilic Globulin”) to cure the blood coagulation disorder of hemophilia patients thanks to the discovery of F.H.L Patek and A.J Taylor <ref>Patek AJ & Taylor FHL. Hemophilia. II. Some properties of a substance obtained from normal human plasma effective in accelerating the coagulation of hemophilic blood. The Journal of clinical investigation. 1937 Jan; 16(1): 113-124. PMID: 16694450 doi: 10.1172/JCI100829</ref>. | ||
'''1964''': Usual utilisation of concentrated factor VIII to treat hemophilia <ref>Dallman PR & Pool JG. Treatment of hemophilia with factor VIII concentrates. New England Journal of Medicine. 1968 Jan ; 278(4): 199-202. PMID: 5711341 doi: 10.1056/NEJM196801252780406</ref>. | '''1964''': Usual utilisation of concentrated factor VIII to treat hemophilia <ref>Dallman PR & Pool JG. Treatment of hemophilia with factor VIII concentrates. New England Journal of Medicine. 1968 Jan ; 278(4): 199-202. PMID: 5711341 doi: 10.1056/NEJM196801252780406</ref>. | ||
